ADAM10 promotes pituitary adenoma cell migration by regulating cleavage of CD44 and L1

Journal of Molecular Endocrinology

Volumn 49, Issue 1, 2012, Pages 21-33

  Pan, Yuan ^a,b   Han, Chong ^a   Wang, Chunlin ^a   Hu, Guohan ^a   Luo, Chun ^a   Gan, Xiaoqiang ^a   Zhang, Fenglin ^a   Lu, Yicheng ^a   Ding, Xuehua ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b 401 Hospital of PLA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ADAM10 ENDOPEPTIDASE; CALGRANULIN; CALMODULIN; HERMES ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE P60; PROTEIN SHC;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CALCIUM TRANSPORT; CANCER CELL; CANCER INVASION; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS ADENOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ADAM PROTEINS; ADENOMA; AMYLOID PRECURSOR PROTEIN SECRETASES; ANTIGENS, CD44; CALCIUM; CALMODULIN; CELL ADHESION; CELL LINE; CELL MOVEMENT; FEMALE; GENE EXPRESSION; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM GRADING; PITUITARY NEOPLASMS; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 84863531612     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-11-0174     Document Type: Article

References (50)

1. Allinson TM, Parkin ET, Turner AJ & Hooper NM 2003 ADAMs family members as amyloid precursor protein a-secretases. Journal of Neuroscience Research 74 342-352. (doi:10.1002/jnr.10737)
2. Arribas J, Bech-Serra JJ & Santiago-Josefat B 2006 ADAMs, cell migration and cancer. Cancer and Metastasis Reviews 25 57-68. (doi:10.1007/s10555-006-7889-6)
3. Barberis L, Wary KK, Fiucci G, Liu F, Hirsch E, Brancaccio M, Altruda F, Tarone G & Giancotti FG 2000 Distinct roles of the adaptor protein Shc and focal adhesion kinase in integrin signaling to ERK. Journal of Biological Chemistry 275 36532-36540. (doi:10.1074/jbc. M002487200)
4. Blobel CP 1997 Metalloprotease-disintegrins: links to cell adhesion and cleavage of TNFa and Notch. Cell 90 589-592. (doi:10.1016/ S0092-8674(00)80519-X)
5. Borrell-Pages M, Rojo F, Albanell J, Baselga J & Arribas J 2003 TACE is required for the activation of the EGFR by TGF-a in tumors. EMBO Journal 22 1114-1124. (doi:10.1093/emboj/cdg111)
6. Brummendorf T, Kenwrick S & Rathjen FG 1998 Neural cell recognition molecule L1: from cell biology to human hereditary brain malformations. Current Opinion in Neurobiology 8 87-97. (doi:10.1016/S0959-4388(98)80012-3)
7. Bulayeva NN & Watson CS 2004 Xenoestrogen-induced ERK-1 and ERK-2 activation via multiple membrane-initiated signaling pathways. Environmental Health Perspectives 112 1481-1487. (doi:10.1289/ehp.7175)
8. Carl-McGrath S, Lendeckel U, Ebert M, Roessner A & Rocken C 2005 The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer. International Journal of Oncology 26 17-24.
9. Crawford HC, Dempsey PJ, Brown G, Adam L & Moss ML 2009 ADAM10 as a therapeutic target for cancer and inflammation. Current Pharmaceutical Design 15 2288-2299. (doi:10.2174/138161209788682442)
10. Daniel L, Trouillas J, Renaud W, Chevallier P, Gouvernet J, Rougon G & Figarella-Branger D 2000 Polysialylated-neural cell adhesion molecule expression in rat pituitary transplantable tumors (spontaneous mammotropic transplantable tumor in Wistar-Furth rats) is related to growth rate and malignancy. Cancer Research 60 80-85.
11. Egeblad M & Werb Z 2002 New functions for the matrix metalloproteinases in cancer progression. Nature Reviews. Cancer 2 161-174. (doi:10.1038/nrc745)
12. Fogel M, Gutwein P, Mechtersheimer S, Riedle S, Stoeck A, Smirnov A, Edler L, Ben-Arie A, Huszar M & Altevogt P 2003 L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas. Lancet 362 869-875. (doi:10.1016/S0140-6736(03)14342-5)
13. Gavert N, Conacci-Sorrell M, Gast D, Schneider A, Altevogt P, Brabletz T & Ben-Ze'ev A 2005 L1, a novel target of b-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. Journal of Cell Biology 168 633-642. (doi:10.1083/jcb.200408051)
14. Gong J, Zhao Y, Abdel-Fattah R, Amos S, Xiao A, Lopes MB, Hussaini IM & Laws ER 2008 Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas. Pituitary 11 37-48. (doi:10.1007/s11102-007-0066-2)
15. Gunthert AR, Strater J, von Reyher U, Henne C, Joos S, Koretz K, Moldenhauer G, Krammer PH &Moller P 1996 Early detachment of colon carcinoma cells during CD95(APO-1/Fas)-mediated apoptosis. I. De-adhesion from hyaluronate by shedding of CD44. Journal of Cell Biology 134 1089-1096. (doi:10.1083/jcb.134.4.1089)
16. Gutwein P, Oleszewski M, Mechtersheimer S, Agmon-Levin N, Krauss K & Altevogt P 2000 Role of Src kinases in the ADAM-mediated release of L1 adhesion molecule from human tumor cells. Journal of Biological Chemistry 275 15490-15497. (doi:10.1074/jbc.275.20.15490)
17. Hartmann D, de Strooper B, Serneels L, Craessaerts K, Herreman A, Annaert W, Umans L, Lubke T, Lena Illert A, von Figura K et al. 2002 The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for a-secretase activity in fibroblasts. Human Molecular Genetics 11 2615-2624. (doi:10.1093/hmg/11.21.2615)
18. Hortsch M 2000 Structural and functional evolution of the L1 family: are four adhesion molecules better than one? Molecular and Cellular Neuroscience 15 1-10. (doi:10.1006/mcne.1999.0809)
19. Ito K, Okamoto I, Araki N, Kawano Y, Nakao M, Fujiyama S, Tomita K, Mimori T & Saya H 1999 Calcium influx triggers the sequential proteolysis of extracellular and cytoplasmic domains of E-cadherin, leading to loss of b-catenin from cell-cell contacts. Oncogene 18 7080-7090. (doi:10.1038/sj.onc.1203191)
20. Kawamoto H, Uozumi T, Arita K, Yano T & Hirohata T 1996 Type IV collagenase activity and cavernous sinus invasion in human pituitary adenomas. Acta Neurochirurgica 138 390-395. (doi:10.1007/BF01420300)
21. Kenny PA & Bissell MJ 2007 Targeting TACE-dependent EGFR ligand shedding in breast cancer. Journal of Clinical Investigation 117 337-345. (doi:10.1172/JCI29518)
22. Kirkegaard T, Edwards J, Tovey S, McGlynn LM, Krishna SN, Mukherjee R, Tam L, Munro AF, Dunne B & Bartlett JM 2006 Observer variation in immunohistochemical analysis of protein expression, time for a change? Histopathology 48 787-794. (doi:10.1111/j.1365-2559.2006.02412.x)
23. Kleiner S, Faisal A & Nagamine Y 2007 Induction of uPA gene expression by the blockage of E-cadherin via Src- and Shc-dependent Erk signaling. FEBS Journal 274 227-240. (doi:10.1111/j.1742-4658.2006.05578.x)
24. Knosp E, Steiner E, Kitz K & Matula C 1993 Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33 610-617 (discussion 617-618). (doi:10.1227/00006123-199310000-00008)
25. Ko SY, Lin SC, Wong YK, Liu CJ, Chang KW & Liu TY 2007 Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma. Cancer Letters 245 33-43. (doi:10.1016/j. canlet.2005.10.019)
26. Lammich S, Kojro E, Postina R, Gilbert S, Pfeiffer R, Jasionowski M, Haass C & Fahrenholz F 1999 Constitutive and regulated a-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. PNAS 96 3922-3927. (doi:10.1073/pnas.96.7.3922)
27. Liu WP, Kunishio K, Matsumoto Y, Okada M & Nagao S 2005 Matrix metalloproteinase-2 expression correlates with cavernous sinus invasion in pituitary adenomas. Journal of Clinical Neuroscience 12 791-794. (doi:10.1016/j.jocn.2005.03.010)
28. Maretzky T, Schulte M, Ludwig A, Rose-John S, Blobel C, Hartmann D, Altevogt P, Saftig P & Reiss K 2005 L1 is sequentially processed by two differently activated metalloproteases and presenilin/gammasecretase and regulates neural cell adhesion, cell migration, and neurite outgrowth. Molecular and Cellular Biology 25 9040-9053. (doi:10.1128/MCB.25.20.9040-9053.2005)
29. McCulloch DR, Akl P, Samaratunga H, Herington AC & Odorico DM 2004 Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaP. Clinical Cancer Research 10 314-323. (doi:10.1158/1078-0432.CCR-0846-3)
30. Mechtersheimer S, Gutwein P, Agmon-Levin N, Stoeck A, Oleszewski M, Riedle S, Postina R, Fahrenholz F, Fogel M, Lemmon V et al. 2001 Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins. Journal of Cell Biology 155 661-673. (doi:10.1083/jcb.200101099)
31. Millichip MI, Dallas DJ, Wu E, Dale S & McKie N 1998 The metallo-disintegrin ADAM10 (MADM) from bovine kidney has type IV collagenase activity in vitro. Biochemical and Biophysical Research Communications 245 594-598. (doi:10.1006/bbrc.1998.8485)
32. Mochizuki S & Okada Y 2007 ADAMs in cancer cell proliferation and progression. Cancer Science 98 621-628. (doi:10.1111/j.1349-7006. 2007.00434.x)
33. Moss ML, Stoeck A, Yan W & Dempsey PJ 2008 ADAM10 as a target for anti-cancer therapy. Current Pharmaceutical Biotechnology 9 2-8. (doi:10.2174/138920108783497613)
34. Murai T, Miyazaki Y, Nishinakamura H, Sugahara KN, Miyauchi T, Sako Y, Yanagida T & Miyasaka M 2004 Engagement of CD44 promotes Rac activation and CD44 cleavage during tumor cell migration. Journal of Biological Chemistry 279 4541-4550. (doi:10.1074/jbc. M307356200)
35. Murakami D, Okamoto I, Nagano O, Kawano Y, Tomita T, Iwatsubo T, De Strooper B, Yumoto E & Saya H 2003 Presenilin-dependent gamma-secretase activity mediates the intramembranous cleavage of CD44. Oncogene 22 1511-1516. (doi:10.1038/sj.onc.1206298)
36. Nagano O, Murakami D, Hartmann D, De Strooper B, Saftig P, Iwatsubo T, Nakajima M, Shinohara M & Saya H 2004 Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2C) influx and PKC activation. Journal of Cell Biology 165 893-902. (doi:10.1083/jcb.200310024)
37. Ohnishi T, Matsumura H, Izumoto S, Hiraga S & Hayakawa T 1998 A novel model of glioma cell invasion using organotypic brain slice culture. Cancer Research 58 2935-2940.
38. Okamoto I, Tsuiki H, Kenyon LC, Godwin AK, Emlet DR, Holgado-Madruga M, Lanham IS, Joynes CJ, Vo KT, Guha A et al. 2002 Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors. American Journal of Pathology 160 441-447. (doi:10.1016/S0002-9440(10)64863-8)
39. Parkin E & Harris B 2009 A disintegrin and metalloproteinase (ADAM)-mediated ectodomain shedding of ADAM10. Journal of Neurochemistry 108 1464-1479. (doi:10.1111/j.1471-4159.2009. 05907.x)
40. Pruessmeyer J & Ludwig A 2009 The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer. Seminars in Cell & Developmental Biology 20 164-174. (doi:10.1016/j.semcdb.2008.09.005)
41. Qian ZR, Sano T, Yoshimoto K, Asa SL, Yamada S, Mizusawa N & Kudo E 2007 Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas. Modern Pathology 20 1269-1277. (doi:10.1038/modpathol.3800965)
42. Sanderson MP, Dempsey PJ & Dunbar AJ 2006 Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors. Growth Factors 24 121-136. (doi:10.1080/08977190600634373)
43. Santiago-Josefat B, Esselens C, Bech-Serra JJ & Arribas J 2007 Posttranscriptional up-regulation of ADAM17 upon epidermal growth factor receptor activation and in breast tumors. Journal of Biological Chemistry 282 8325-8331. (doi:10.1074/jbc.M608826200)
44. Schachner M 1997 Neural recognition molecules and synaptic plasticity. Current Opinion in Cell Biology 9 627-634. (doi:10.1016/S0955-0674(97)80115-9)
45. Seals DF & Courtneidge SA 2003 The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes and Development 17 7-30. (doi:10.1101/gad.1039703)
46. Thies A, Schachner M, Moll I, Berger J, Schulze HJ, Brunner G & Schumacher U 2002 Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma. European Journal of Cancer 38 1708-1716. (doi:10.1016/S0959-8049(02)00105-3)
47. White JM 2003 ADAMs: modulators of cell-cell and cell-matrix interactions. Current Opinion in Cell Biology 15 598-606. (doi:10.1016/j.ceb.2003.08.001)
48. Wu E, Croucher PI & McKie N 1997 Expression of members of the novel membrane linked metalloproteinase family ADAM in cells derived from a range of haematological malignancies. Biochemical and Biophysical Research Communications 235 437-442. (doi:10.1006/bbrc.1997.6714)
49. Yoshimura T, Tomita T, Dixon MF, Axon AT, Robinson PA & Crabtree JE 2002 ADAMs (a disintegrin and metalloproteinase) messenger RNA expression in Helicobacter pylori-infected, normal, and neoplastic gastric mucosa. Journal of Infectious Diseases 185 332-340. (doi:10.1086/338191)
50. Zhou BB, Peyton M, He B, Liu C, Girard L, Caudler E, Lo Y, Baribaud F, Mikami I, Reguart N et al. 2006 Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in nonsmall cell lung cancer. Cancer Cell 10 39-50. (doi:10.1016/j.ccr.2006.05.024)